Search | VHL Regional Portal

Acute severe hypoxaemia after mechanical ventilation in a patient with an Ebstein anomaly requiring extracorporeal membrane oxygenation.

Chimot, L; Mascle, S; Chabanne, C; Flecher, E; De Latour, B; Lavoué, S; Le Tulzo, Y.

Br J Anaesth ; 107(6): 1010-2, 2011 Dec.

Article in English | MEDLINE | ID: mdl-22088878

Subject(s)

Ebstein Anomaly/complications , Extracorporeal Membrane Oxygenation , Hypoxia/therapy , Respiration, Artificial/adverse effects , Acute Disease , Foramen Ovale, Patent/complications , Humans , Hypoxia/etiology , Male , Middle Aged

[Acute traumatic haemorrhagic shock and transfusion: what's new in 2009?]. / Prise en charge transfusionnelle du choc hémorragique d'origine traumatique à la phase aiguë: quoi de neuf en 2009 ?

Morel, N; Morel, O; Chimot, L; Lortet, V; Julliac, B; Lelias, A; Merson, L; Dabadie, Ph.

Ann Fr Anesth Reanim ; 28(3): 222-30, 2009 Mar.

Article in French | MEDLINE | ID: mdl-19278810

ABSTRACT

In spite of continuous progress in surgery and in interventional radiology, massive haemorrhage remains a leading cause of death in traumatology. The transfusional strategy appears a key step in the treatment of haemorrhagic shock. In the light of new insights into the pathophysiology of coagulopathies associated with traumatic shock it seems reasonable to transfuse patients with haemorrhagic shock earlier than previously recommended.

Subject(s)

Blood Transfusion/methods , Emergency Medical Services/methods , Shock, Hemorrhagic/therapy , Wounds and Injuries/complications , Acidosis/etiology , Acidosis/physiopathology , Acidosis/therapy , Acute Disease , Antigens/therapeutic use , Blood Coagulation Disorders/drug therapy , Blood Coagulation Disorders/etiology , Blood Coagulation Disorders/mortality , Blood Coagulation Disorders/physiopathology , Blood Coagulation Disorders/therapy , Blood Transfusion/trends , Blood Volume , Combined Modality Therapy , Factor VII/therapeutic use , Humans , Hypotension/etiology , Hypotension/physiopathology , Hypotension/therapy , Hypothermia/etiology , Hypothermia/physiopathology , Hypothermia/therapy , Hypoxia/etiology , Hypoxia/physiopathology , Hypoxia/therapy , Recombinant Proteins/therapeutic use , Shock, Hemorrhagic/blood , Shock, Hemorrhagic/etiology , Shock, Hemorrhagic/physiopathology , Time Factors

Subject(s)

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL